Search

Your search keyword '"CD26"' showing total 658 results

Search Constraints

Start Over You searched for: Descriptor "CD26" Remove constraint Descriptor: "CD26" Language english Remove constraint Language: english
658 results on '"CD26"'

Search Results

1. Exploring CD26−/lo subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4+ T cell subset expressing archetypical granulocyte proteins.

2. Peripheral blood quantitation of CD26 positive leukemic stem cells as a predictor of tyrosine kinase inhibitor response in chronic myeloid leukemia.

3. CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.

4. Could Flow Cytometry Provide New Prognostic Markers in Colorectal Cancer?

5. Molecular basis for receptor recognition and broad host tropism for merbecovirus MjHKU4r-CoV-1.

6. Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy.

7. Impact of inpatient management of hyperglycemia on peripheral T cell markers in patients with type 2 diabetes.

8. ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB

9. Predicting drug resistance

10. Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response

11. Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury.

12. Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease.

13. Molecular insights on the coronavirus MERS-CoV interaction with the CD26 receptor

14. Targeting cluster of differentiation 26 / dipeptidyl peptidase 4 (CD26/DPP4) in organ fibrosis.

15. Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients

16. Analysis of IL‐10 and IL‐35 in dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid.

17. Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR).

18. Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

19. CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia.

20. Dipeptidyl peptidase-4 cell surface expression marks an abundant adipose stem/progenitor cell population with high stemness in human white adipose tissue

21. Differential expression of carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) and dipeptidyl peptidase‐4 (DPP4) with detection of Middle East respiratory syndrome-coronavirus in peripheral blood

22. Differential Anti-Tumor Effects of IFN-Inducible Chemokines CXCL9, CXCL10, and CXCL11 on a Mouse Squamous Cell Carcinoma Cell Line.

23. Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients.

24. The Role of Serum CD26 in the Diagnosis of Gastric Cancer

25. CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells

26. CD26lowPD-1+ CD8 T cells are terminally exhausted and associated with leukemia progression in acute myeloid leukemia

27. Functional roles of CD26/DPP4 in bleomycin‐induced pulmonary fibrosis.

28. The number of circulating CD26 expressing cells is decreased in critical COVID‐19 illness.

29. Functional roles of CD26/DPP4 in bleomycin‐induced pulmonary fibrosis

30. Inhibition of dipeptidyl-peptidase 4 induces upregulation of the late cornified envelope cluster in keratinocytes.

31. Differential expression of carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) and dipeptidyl peptidase‐4 (DPP4) with detection of Middle East respiratory syndrome-coronavirus in peripheral blood.

32. SARS-CoV-2 cell entry beyond the ACE2 receptor.

33. CD49d and CD26 in chronic lymphocytic leukemia: their correlation with clinical Binet staging and clinical parameters.

34. Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response.

35. Predicting drug resistance.

36. Exploring CD26 -/lo subpopulations of lymphocytes in asthma phenotype and severity: A novel CD4 + T cell subset expressing archetypical granulocyte proteins.

37. Altered expressions of CXCR4 and CD26 on T-helper lymphocytes in hereditary hemorrhagic telangiectasia

38. CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma

39. Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies

40. Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology.

41. CD26 is a senescence marker associated with reduced immunopotency of human adipose tissue-derived multipotent mesenchymal stromal cells.

42. cd26 Knockdown Negatively Affects Porcine Parthenogenetic Preimplantation Embryo Development.

43. CD14 and CD26 from serum exosomes are associated with type 2 diabetes, exosomal Cystatin C and CD14 are associated with metabolic syndrome and atherogenic index of plasma.

44. CD14 and CD26 from serum exosomes are associated with type 2 diabetes, exosomal Cystatin C and CD14 are associated with metabolic syndrome and atherogenic index of plasma

45. Dipeptidyl peptidase 4-positive cancer-associated fibroblasts enhance lung adenocarcinoma growth.

46. CD26 expression on circulating CD34+/CD38‐ progenitor population is a specific and reliable tool for the rapid flow cytometric diagnosis of chronic myeloid leukemia—A single‐center validation study.

47. Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia.

48. Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus

50. Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?

Catalog

Books, media, physical & digital resources